ibrutinib,rituximab
abbvie,janssen
[' ibru']
triangle study, n=870 rct, mcl, ibrutinib (w maint) superior to autohct after initial induction. #ash22 
Sarah Cannon Cancer Blood Cancer Network;
 #NIHBMTLateEffects   #Celltherapy #HSCT #BMT #Survivorship; Tweets/opinions are personal